Importantly, in neoplastic diseases, HSP expression is usually increased, which has been confirmed in gastric cancer [26], breast cancer [27], endometrial cancer, ovarian cancer [28,29], gastrointestinal cancers [30], lung cancer [31] and in prostate cancer [32]. This evidence concerns the gene HSP90B2P and neoplasm.